Recent News

• 03.11.2025 - LENZ Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights on March 19, 2025
• 03.03.2025 - LENZ Therapeutics to Host Commercial Day on April 15, 2025
• 02.24.2025 - LENZ Therapeutics to Participate in Upcoming Investor Conferences
• 11.12.2024 - LENZ Therapeutics to Participate in Upcoming Investor Conferences
• 11.06.2024 - LENZ Therapeutics Reports Third Quarter 2024 Financial Results
• 11.06.2024 - LENZ Therapeutics Reports Third Quarter 2024 Financial Results
• 10.30.2024 - LENZ Therapeutics to Report Third Quarter Financial Results and Business Update on November 6, 2024

Recent Filings

• 03.07.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.13.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.13.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.13.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.13.2025 - 4 Statement of changes in beneficial ownership of securities
• 12.17.2024 - 4 Statement of changes in beneficial ownership of securities
• 11.14.2024 - SC 13G/A Statement of Beneficial Ownership by Certain Investors
• 11.08.2024 - SC 13D/A General Statement of Acquisition of Beneficial Ownership
• 11.06.2024 - 424B3 Prospectus [Rule 424(b)(3)]
• 11.06.2024 - 10-Q Quarterly report [Sections 13 or 15(d)]